Funding profile · Health IT, frontline workforce

Elemeno Health

About $23 million disclosed across nine Regulation D offerings and three crowdfunding portals since 2016. The last securities notice was filed in February 2024. The company closed 2025 with $333,284 in cash.

$20.6MReported sold across nine Form D offerings, 2016 to 2024
$2.4MRaised from three Reg CF portals: Republic, StartEngine, Wefunder
$6.0MPre-money valuation in the 2024 Wefunder offering, against $20.0M in 2021
$333KCash at Dec 31, 2025, per the Form C-AR

Data as of September 22, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2016 to 2017 Founding notes and seed, four offerings $3,154,265 combined 72 across the four; Ed Nanale listed as promoter and 10% stockholder Form D
Mar to Jul 2020 Two SAFE offerings, later amended upward $937,687 and $600,000 7 and 8 Form D/A
Sep 2020 Reg CF on Republic, SAFE $1,070,000 at a $12.0M cap Retail; the founder said nearly 4,000 healthcare workers and patients invested Portal data
Nov 2021 Reg CF on StartEngine, preferred $1,234,241 at a $20,028,610 valuation Retail Portal data
May 2022 Series A, announced as $7 million $6,487,499 sold of $8,000,000 18; led by SJF Ventures, joined by SustainVC Form D and release
Mar 2023 Preferred equity, first sale Dec 17, 2021 $6,025,692 of $6,025,692 35 Form D
Feb 2024 Preferred equity $3,350,344 sold of $5,000,000 80 Form D
Aug 2024 to Jan 2025 Reg CF on Wefunder, Series Seed preferred About $143,000 at a $6.0M pre-money 157 on the portal page Form C and portal

What the filings show

Elemeno Health, Inc. · Form D · filed Feb 29, 2024

First sale
Nov 16, 2023
Offered
$5,000,000 equity
Sold
$3,350,344 · $1,649,656 remaining
Investors
80 · average about $41,900
Exemption
Rule 506(b)
Related persons
Arup Roy-Burman (executive officer, director); Linda Hand (executive officer, director); Crista Bailey, Arrun Kapoor, Alan Kelley (directors)
Filing
SEC EDGAR, CIK 0001805018

Elemeno Health, Inc. · Form D · filed Mar 22, 2023

First sale
Dec 17, 2021, fifteen months before the filing date
Offered
$6,025,692 equity
Sold
$6,025,692 · nothing remaining
Investors
35 · average about $172,200
Exemption
Rule 506(b)
Related persons
Arup Roy-Burman (executive officer, director); Scott Cohen (executive officer); Arrun Kapoor, Crista Bailey (directors)
Filing
SEC EDGAR, CIK 0001805018

Elemeno Health, Inc. · Form D · filed May 12, 2022

First sale
Apr 26, 2022
Offered
$8,000,000 equity
Sold
$6,487,499 · $1,512,501 remaining
Investors
18 · average about $360,400
Exemption
Rule 506(b)
Related persons
Arup Roy-Burman (executive officer, director); Arrun Kapoor, Crista Bailey (directors)
Filing
SEC EDGAR, CIK 0001805018

Elemeno Health, Inc. · Form C-AR · filed Apr 6, 2026

Period
Fiscal year ended Dec 31, 2025
Revenue
$2,623,648, against $2,420,278 in 2024
Net loss
$1,445,890, against $2,537,697 in 2024
Cash
$333,284, against $864,994 a year earlier
Balance sheet
Total assets $715,215; short term debt $1,732,939
Employees
18, against 20 at the August 2024 filing

Reading the filings

  1. The average check fell by almost nine tenths in two years.May 2022: $6,487,499 from 18 investors, about $360,400 each. March 2023: $6,025,692 from 35, about $172,200 each. February 2024: $3,350,344 from 80, about $41,900 each. Dollars roughly halved while the investor count more than quadrupled: the signature of a round filled with small checks rather than a lead.
  2. Announced and filed do not match.The May 12, 2022 release called it a $7 million Series A. The Form D filed that same day reported $6,487,499 sold of $8,000,000 offered. No amendment followed.
  3. One notice arrived fifteen months late.The Form D filed March 22, 2023 reports a first sale of December 17, 2021. Regulation D asks for the notice within 15 days of first sale. That sale also predates the April 2022 sale in the earlier notice, so the two offerings were reported in reverse order.
  4. The valuation went backwards.StartEngine priced the November 2021 crowdfunding at a $20,028,610 valuation. The Form C filed August 2024 set the share price at $0.05686 on a $6,000,000 pre-money, $5,000,000 for the first $500,000 invested. That is roughly a 70 percent cut, stated in the company’s own SEC filing rather than inferred.
  5. Growth does not match the growth award.Revenue was $1,515,596 in 2022 and $2,623,648 in 2025, about 73 percent over three years. The August 2026 release announcing the company’s second Inc. 5000 placement puts the median three year growth among that year’s honorees at 130 percent.
  6. The runway is the open question.Cash fell from $864,994 to $333,284 during 2025 against a net loss of $1,445,890, with $1,732,939 of short term debt. The loss is narrowing, but no equity notice has been filed since February 2024, when $1,649,656 of a $5,000,000 offering went unsold.

Commercial signals

Signal Detail Source type
Revenue $1,515,596 (2022), $1,718,775 (2023), $2,420,278 (2024), $2,623,648 (2025) SEC filings
Losses $4,006,183 (2022), $5,038,549 (2023), $2,537,697 (2024), $1,445,890 (2025) SEC filings
Headcount 20 employees at the August 2024 filing, 18 at the April 2026 filing SEC filings
Named customers UCSF Health, El Camino Health, LCMC Health, OSF HealthCare, UHS Northern Nevada, Northside Hospital. OSF and El Camino have described their use publicly. Independent
Deployment count 40 hospitals (Wefunder offering), 70 or more (Aug 2025 and May 2026 releases), more than 100 hospitals and clinics and more than 85 hospitals in the same Aug 2026 release Claims disagree
Channel Swisslog Healthcare partnership, May 2026, which the company says reaches more than 300 hospitals in North America. Piloted at Hoag Hospitals in 2025. Company-stated

What to watch

  • A new Form D or Form C. Nothing since February 2024.
  • The Form C-AR for fiscal 2026, due in spring 2027, which will show whether cash stabilized.
  • Whether the Swisslog channel appears as revenue rather than as a press release.
  • Whether the 2024 down round is followed by a priced round at a higher valuation, or by a sale.
  • Whether the hospital count converges on a single figure across marketing and securities filings.

The Elemeno Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Pharos: Also in Healthcare IT. An AI system that reads hospital charts and produces the quality measures nurses now extract by hand
  • CoreCare: Also in Healthcare IT. A Y Combinator backed platform that automates eligibility, census and Medicaid workflows for skilled nursing facilities
  • Medisas: Also in Healthcare IT. A hospital doctor who could program set out to replace the scrap of paper that care teams pass between shifts
  • Medumo: Also in Healthcare IT. A Boston company that texted patients through the hours before a colonoscopy or a surgery

Sources

  1. Public recordForm D, Elemeno Health, Inc.SEC · Feb 29, 2024
  2. Public recordForm D, Elemeno Health, Inc.SEC · Mar 22, 2023
  3. Public recordForm D, Elemeno Health, Inc.SEC · May 12, 2022
  4. Public recordSeven Form D and Form D/A notices covering 2016 to 2020 offeringsSEC · Apr to Jul 2020
  5. Public recordForm C offering statement with fiscal 2023 and 2022 financials and share pricingSEC · Aug 6, 2024
  6. Public recordForm C-AR annual report, fiscal year 2025SEC · Apr 6, 2026
  7. IndependentElemeno Health on Wefunder 2024, financing history and valuationsKingscrowd · Aug 6, 2024
  8. CompanyElemeno Health Closes Equity FinancingBusiness Wire · May 12, 2022
  9. CompanyElemeno Health Earns Back-to-Back Inc. 5000 RecognitionEIN Presswire · Aug 11, 2026
  10. CompanyElemeno Health Announces Strategic Partnership with Swisslog HealthcarePR Newswire · May 27, 2026
  11. CompanyInvest in Elemeno Health, offering page and quick factsWefunder · accessed Sep 22, 2026

Compiled from SEC and other public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date and may not capture later sales. Healthcare Venture Capital Fund holds no position in Elemeno Health. This page is not an offer to sell or a recommendation to buy any security.